Article

Top Consideration For Onshoring Pharmaceutical Manufacturing: Find The Right CMO

Source: AbbVie
iStock-1274446171-shipping-logistics-plane-data

The Covid-19 pandemic pulled the curtain back and showed the American people the pharmaceutical supply chain's vulnerabilities, highlighting the U.S' dependency on China and other countries. Over the last few decades, drug manufacturers have been gradually moving production offshore, but policymakers and others are examining the need to bring manufacturing back to the U.S. When drug and API manufacturers decide to make the onshoring shift, they should be prepared with a well-designed quality system and a thorough tech transfer process. Partnering with the right CMO will ensure a smoother transfer.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: